Teva Pharmaceutical Industries Stock News

Admitting to success is a lot easier than failure and when it comes to stocks, not only is there money involved, but also questioning your — or your advisor's — judgment. And then there is the a

Upgrades Wolfe Research upgraded the previous rating for Landstar System Inc (NASDAQ:LSTR) from Underperform to Peer Perform. In the fourth quarter, Landstar System showed an EPS of $2.99, compared to

TEL AVIV, Israel--(BUSINESS WIRE)--Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) announced today that it will issue a press release on its first quarter 2022 financial results on Tuesday,

West Virginia's attorney general urged a judge to hold Johnson & Johnson (NYSE: JNJ), Teva Pharmaceuticals Industries Ltd (NYSE: TEVA), and AbbVie Inc's (NYSE: ABBV) Allergen accountable for ca

Florida has reached more than $878 million in settlements with CVS Health Corp (NYSE: CVS) and three drug companies to resolve claims and avert a trial next month over their roles in fueling an opio

Why bother buying shares of heavily indebted companies with receding revenue?

Shares of Teva Pharmaceutical Industries Ltd. TEVA, +5.81% hiked up 5.0% toward a six-week high in afternoon trading Friday, putting them on track for a ninth-straight gain, after Bernstein analyst Aa

Teva Pharmaceutical Industries Ltd (NYSE:TEVA) stock was last seen up 4.7% at $8.55 this morning, following an upgrade from Bernstein.

The price of Teva Pharmaceutical stock has seen a fall of 17% in a month, while it is down 34% in the last year. The shares of generic drug makers have largely underperformed the broader markets over

The first trial in Rhode Island state court against Teva Pharmaceutical Industries Ltd''s (NYSE: TEVA ) alleged responsibility for the opioid crisis begins jury selection Monday . The case begins over whether Teva contributed to an opioid crisis that has caused more than 500,000 deaths over the past two decades. Rhode Island says Teva created a "public nuisance" by downplaying … Full story available on Benzinga.com

By Dietrich Knauth (Reuters) – Rhode Island is set to square off on Monday against Teva Pharmaceutical Industries Ltd, as a multibillion-dollar trial begins over whether the Israeli company contributed to an opioid crisis that has caused more than 500,000 deaths over the past two decades.

AbbVie's (ABBV) new oral anti-CGRP drug, Qulipta, demonstrates potential to reduce monthly migraine days in adults with chronic migraine in a phase III study.

Natco Pharma And Teva Launch Revlimid In The US: ICICI Securities

Teva Pharmaceuticals (TEVA) has launched the first generic version of Bristol-Myers Squibb''s (BMY) Revlimid (lenalidomide) for multiple myeloma and several types of leukemia.

The shares of Viatris (VTRS) and Teva (VTRS) have well underperformed the broader market over the past 12 months. Find out the opportunities.